跳至主要内容
临床试验/DRKS00023745
DRKS00023745已完成未知

Clinical Study to Assess the Impact of a Bacterial- and Yeast-based Nutritional Supplement (SugarBurner) on Glucose Control in Patients with Type 2 Diabetes mellitus

Sugarburner AB0 个研究点目标入组 46 人开始时间: 2020年12月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • 1.age > 18 years
  • 2. diagnosed type 2 diabetes mellitus
  • 3. HbA1c value within the last 2 months before screening visit > 6.0% and < 9.9%
  • 4. receiving one or a combination of the following antidiabetic treatments:
  • lifestyle only (diet and exercise)
  • oral antidiabetic treatment
  • GLP1-analogs
  • insulin treatment

排除标准

  • 1. Diabetes mellitus type 1
  • 2. Acute or chronic gastrointestinal disease
  • 4. Acute hyperthyreosis (TSH value not within normal range)
  • 5. History of severe or multiple allergies
  • 6. Known allergy against probiotic nutritional supplements
  • 7. Participation in a clinical trial within 3 months before trial entry.
  • 8. Progressive fatal diseases
  • 9. Drug or alcohol abuse within the last 5 years
  • 10. Lack of compliance or other similar reason, that, the investigator believes, precludes satisfactory participation in the study

研究者

发起方
Sugarburner AB

相似试验

Clinical Study to Assess the Impact of a Bacterial-... | 临床试验